Avadel Pharmaceuticals Stock Forecast for 2023 - 2025 - 2030

Updated on 03/18/2024

Stock Rating
10
Price Target
$22.00
Consensus
Outperform
Upside
37.50%
Analysts
1
Stock Rating
10
Upside
37.50%
Analysts
1
Price Target
$22.00

Avadel Pharmaceuticals Stock Forecast and Price Target

According to experts, who recently provided their 2024 price targets for Avadel Pharmaceuticals, the average price target is $22.00, with a high estimate of $29.00 and a low estimate of $19.00. That is a potential upside of approximately 37.5% from the last closing price of $16.00 on March, 2024. Even if you are not interested in AVDL stock, you should still be aware of its competitors.

$22.00

37.50% Upside

Buy
Buy

Avadel Pharmaceuticals Fair Value Forecast for 2023 - 2025 - 2030

In the last four years, Avadel Pharmaceuticals's Price has increased by 100.00%, going from $0.00 to $0.00. In the next year, analysts are expecting an increase in Fair Value, predicting it will reach $17.18 – an increase of 100.00%. The Avadel Pharmaceuticals forecast is for Fair Value to reach $29.38 or grow by 100.00%.

2024 Fair Value Forecast
$17.18
2025 Fair Value Forecast
$18.78
2026 Fair Value Forecast
$20.54
2027 Fair Value Forecast
$22.47
2028 Fair Value Forecast
$24.57
2029 Fair Value Forecast
$26.87
2030 Fair Value Forecast
$29.38

Avadel Pharmaceuticals Revenue Forecast for 2023 - 2025 - 2030

In the last year, Avadel Pharmaceuticals's Revenue has increased by 25.21%, going from $22.33M to $27.96M. In the next year, analysts are expecting an increase in Revenue, predicting it will reach $142.87M – an increase of 410.98%. The Avadel Pharmaceuticals forecast is for Revenue to reach $437.37M or grow by 1464.27%.

2024 Rev Forecast
$0.14B
2025 Rev Forecast
$0.28B
2026 Rev Forecast
$0.36B
2027 Rev Forecast
$0.41B
2028 Rev Forecast
$0.46B
2029 Rev Forecast
$0.48B
2030 Rev Forecast
$0.44B

Avadel Pharmaceuticals Dividend per Share Forecast for 2023 - 2025 - 2030

2024 DPS Forecast
$0.00
2025 DPS Forecast
$0.00
2026 DPS Forecast
$0.00
2027 DPS Forecast
$0.00
2028 DPS Forecast
$0.00
2029 DPS Forecast
$0.00
2030 DPS Forecast
$0.00

Avadel Pharmaceuticals Free Cash Flow Forecast for 2023 - 2025 - 2030

2024 FCF Forecast
$0.02B
2025 FCF Forecast
$0.10B
2026 FCF Forecast
$0.19B
2027 FCF Forecast
$0.18B
2028 FCF Forecast
$0.23B
2029 FCF Forecast
$0.25B
2030 FCF Forecast
$0.26B

Avadel Pharmaceuticals EBITDA Forecast for 2023 - 2025 - 2030

In the last three years, Avadel Pharmaceuticals's EBITDA has grown, increasing from $-34.97M to $-136.08M – a growth of 289.13%. In the following year, 1 experts forecast Avadel Pharmaceuticals's EBITDA will decrease by 109.30%, to $12.65M. In 2030, professionals predict that Avadel Pharmaceuticals's EBITDA will decrease by 1012.53%, to $1.24B.

2024 EBITDA Forecast
$0.01B
2025 EBITDA Forecast
$0.26B
2026 EBITDA Forecast
$-862386972.00
2027 EBITDA Forecast
$2.42B
2028 EBITDA Forecast
$1.60B
2029 EBITDA Forecast
$1.84B
2030 EBITDA Forecast
$1.24B

Avadel Pharmaceuticals EBIT Forecast for 2023 - 2025 - 2030

In the last three years, Avadel Pharmaceuticals's EBIT has grown by 276.02%, from $-36.66M to $-137.85M. According to 7 major analysts, Avadel Pharmaceuticals's EBIT will fall by 72.62% in the next year, reaching $-37.74M. Professionals believe that By 2030, Avadel Pharmaceuticals's EBIT will fall to $291.00M– a 311.10% decrease from its current value.

2024 EBIT Forecast
$-37740000.00
2025 EBIT Forecast
$0.10B
2026 EBIT Forecast
$0.16B
2026 EBIT Forecast
$0.16B
2027 EBIT Forecast
$0.22B
2028 EBIT Forecast
$0.25B
2029 EBIT Forecast
$0.27B
2030 EBIT Forecast
$0.29B

Avadel Pharmaceuticals EPS Price Prediction Forecast for 2023 - 2025 - 2030

In the last four years, Avadel Pharmaceuticals's EPS has increased by 100.00%, going from $-0.66 to $0.00. In the next year, analysts are expecting an increase in EPS, predicting it will reach $-0.34 – an increase of 100.00%. The Avadel Pharmaceuticals forecast is for EPS to reach $1.91 or grow by 100.00%.

2024 EPS Forecast
$-0.34
2025 EPS Forecast
$0.92
2026 EPS Forecast
$1.58
2027 EPS Forecast
$2.05
2028 EPS Forecast
$1.77
2029 EPS Forecast
$2.05
2030 EPS Forecast
$1.91